Severe numbness of the mouth and tongue induced by piperacillin/tazobactam: a rare case report.
Clinicians should be aware that severe adverse reactions to piperacillin/tazobactam can occur, even shortly after administration, and should monitor patients closely.
Where it sits
this study against the rest of the dulaglutide corpusSummary and findings
This case report describes a 58-year-old man who experienced severe oral and tongue numbness, dyspnea, and pruritus approximately 4 minutes after receiving intravenous piperacillin/tazobactam. The adverse reaction was identified as a previously unreported severe adverse drug reaction. No specific dose information was provided in the abstract.
Abstract
<h4>Background</h4>Severe oral and tongue numbness induced by piperacillin/tazobactam is extremely rare.<h4>Results</h4>A 58-year-old man with bacterial pneumonia developed oral and tongue numbness, dyspnea, and pruritus approximately 4 minutes after intravenous infusion of piperacillin/tazobactam. Based on adverse drug reaction causality assessment, this event was identified as a previously unreported severe adverse drug reaction.<h4>Discussion</h4>This case suggests that during clinical use of piperacillin/tazobactam, clinicians should remain vigilant for rare but severe adverse drug reactions even when skin testing is negative, and strengthen medication monitoring to ensure medication safety.
Background
This paper addresses the rare occurrence of severe oral and tongue numbness as an adverse reaction to piperacillin/tazobactam. While adverse drug reactions are known to occur with various medications, this specific reaction appears to be previously unreported. Understanding such rare reactions is critical for improving medication safety and monitoring practices in clinical settings.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
The findings highlight the importance of vigilance in monitoring for rare adverse drug reactions, even when prior testing does not indicate sensitivity. However, due to the nature of a single case report, the findings may not be broadly applicable or clinically significant across larger populations.
Key findings
- Severe oral and tongue numbness occurred 4 minutes after intravenous infusion of piperacillin/tazobactam.
- The patient was a 58-year-old man with bacterial pneumonia.
- The adverse reaction was classified as a previously unreported severe adverse drug reaction.
Limitations
- Single case report limits generalizability.
- No specific dose or duration of treatment reported.
- Lack of larger sample size to support findings.
- No follow-up data provided.